This year’s conference will follow and expand on last year’s event and will provide the audience with the latest updates and developemnts in the COPD industry both from pharmaceutical companies and academia alike.
According to the World Health Organisation (WHO), COPD is set to become the third leading cause of death worldwide by 2030. There is therefore an imperative need for all stakeholders to come together in order to tackle this disease. With the market for COPD growing year on year, new drug/compound development, innovation and management strategies are required to combat this disease. This conference will therefore bring togther major industry stakeholders within COPD to discuss, evaluate and review the latest development in the market.
This year’s agenda will start with an overview of COPD while addressing the regulatory aspects and looking at market access. The focus will then be on managing exacerbation and comorbidities, enuring a successful clinical trial design and challenges in drug development. New sessions will be added, namely patient care, anxiety and depression in COPD, COPD and phenotyping and telehealth.
Hear the story from the other side: Jim & Mary Nelson have kindly accepted to share their story and battle with COPD. Don’t miss the oppportunity to gain more insight from them!
- Accomodating Regulatory and Hta Needs in a Common Development Track: a Case Study – Marcello Milano
- Market Access in Europe – Mercedes Prior and Leandro Lindner
- COPD and Comorbidities – John Hurst
- Anxiety and Depression in COPD – Abebaw Yohannes
- Challenges to Modelling Exacerbations in COPD Using Animal Models – Carla Bauer
- Morning and Evening Symptoms in COPD – Rosa Lamarca
- An Innovative and New Inhaler for COPD Patients – Ewan Walters
- Importance of Biomarker in COPD – Thomas Schlange
- COPD Phenotyping: the Future of COPD
- Lung Disease from the Other Side – Patient and Caregiver – Jim & Mary Nelson
- RPL554 in COPD Clinical/pre-clinical Trials – Jan-Anders Karlsson
- An Immunological Role for Non-neuronal Cholinergic Signalling via Muscarinic Receptors – Corinna Schnoeller
- New Pathways for COPD – Matthew Catley
- Telehealth – Experience of Service Delivery in COPD – Lawrence Gora
- Comprehensive COPD Management Through Novel It Solutions – Simon Bourne and Mal North
- Effective COPD Education Programs: Empowered Patients Are Healthier Patients – Michael Hess
Workshop: Solutions to COPD
This workshop is an introduction to COPD and current best practice. We will discuss signs & symptoms; we will compare COPD and Asthma and review diagnosis. Delegates attending the workshop will have an overview of Spirometry and therapeutic management covering management and prevention of exacerbations in Primary Care.
This workshop will provide a theoretical understanding of COPD and include a practical element. It will be suitable for Nurses, Practice Nurses, District Nurses and Nurses specializing in Respiratory Care.
Who should attend?
Chief Executives, Chief Scientific Officers, Vice Presidents, Heads, Directors, Prinicple Scientists, Associates, Project Leaders, Specialists, and Managers in the following areas:
- Respiratory Physiology & Medicine
- Respiratory Pharmacology
- Medical Affairs
- Inflammatory Disease
- Respiratory, Inflammation and Autoimmunity
- Pulmonary Disease
- Respiratory Therapeutics
- Medical & Inhalation Devices
- In-Vitro Biology
- Inflammation Discovery
- Preclinical R&D
- Clinical Pharmacology
- Clinical Trials
- Clinical Science
- Global Data Informatics
- Business Development
- Brand Manager
- Respiratory Licensing & Regulation